Seeing Is Believing
with an average price target of $18.36. This is a potential upside of $18.36 (0%) from yesterday's end of day stock price of $0.
Aimmune Therapeutics's activity chart (see below) currently has 112 price targets and 80 ratings on display.
Analysts average stock forecasts to be materialized ratio is 30.03% with an average time for these price targets to be met of 126.62 days.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 01-Sep-2020. First documented stock forecast 31-Aug-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18
4 years 2 months 28 days ago
(01-Sep-2020)
4/4 (100%)
$3.19 (21.54%)
176
Hold
$34.5
$0.01 (0.03%)
$66
4 years 2 months 29 days ago
(31-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
4 years 2 months 29 days ago
(31-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
4 years 2 months 29 days ago
(31-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
Buy
$50
$15.51 (44.97%)
$50
4 years 3 months 4 days ago
(25-Aug-2020)
0/5 (0%)
$37.24 (291.85%)
What is AIMT (Aimmune Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?
Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?